Medrhythms
Digital therapeutics company that uses sensors, music, and software to build evidence-based, neurologic interventions to measure and improve walking.
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 24 % | 61 % | 55 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
MedRhythms is a pioneering company in the field of neurotherapeutics, focusing on the development of advanced solutions to improve walking, mobility, and related functional outcomes for individuals with neurologic injuries and diseases. The company operates in the healthcare and medical technology market, serving patients who suffer from persistent walking deficits and other movement disorders. MedRhythms employs a proprietary, patented technology platform that combines sensors, software, and music with advanced neuroscience to target neural circuitry and enhance brain health. The business model revolves around the creation and distribution of these innovative therapeutic solutions, generating revenue through the sale of their technology and services to healthcare providers and patients. Headquartered in Portland, Maine, MedRhythms has a hybrid workforce with employees located across the United States, all dedicated to the company's mission of improving the lives of those affected by neurologic conditions.
Keywords: neurotherapeutics, mobility, brain health, neurologic injuries, movement disorders, patented technology, sensors, software, music, neuroscience.